Prenatal bisphenol A exposure contributes to Tau pathology: Potential roles of CDK5/GSK3β/PP2A axis in BPA-induced neurotoxicity

Toxicology. 2020 May 30:438:152442. doi: 10.1016/j.tox.2020.152442. Epub 2020 Apr 8.

Abstract

Bisphenol A (BPA) is a well-known endocrine disruptor used to manufacture polycarbonate plastics and epoxy resins. BPA exposure especially occupational perinatal exposure to has been linked to numerous adverse effects for the offspring. Available data have shown that perinatal exposure to BPA contributes to neurodegenerative pathological changes; however, the potential mechanisms remain unclear. This study attempted to investigate the long-term consequences of perinatal exposure to BPA on the offspring mouse brain. The pregnant mice were given either a vehicle control or BPA (2, 10, 100 μg/kg/d) from day 6 of gestation until weaning (P6-PND21, foetal and neonatal exposure). At 3, 6 and 9 months of age, the neurotoxic effects in the offspring in each group were investigated. We found that the spine density but not the dendritic branches in the hippocampus were noticeably reduced at 6 and 9 months of age. Meanwhile, p-Tau, the characteristic protein for tauopathy, was dramatically increased in both the hippocampus and cortex at 3-9 months of age. Mechanically, the balance of kinase and protein phosphatase, which plays critical roles in p-Tau regulation, was disturbed. It indicated that GSK3β and CDK5, two critical kinases, were activated in most of the BPA perinatal exposure group, while protein phosphatase 2A (PP2A), one of the important phosphatases, regulated p-Tau expression through its demethylation, methylation and phosphorylation. Taken together, the present study may be translatable to the human occupational BPA exposure due to a similar exposure level. BPA perinatal exposure causes long-term adverse effects on the mouse brain and may be a risk factor for tauopathies, and the CDK5/GSK3β/PP2A axis might be a promising therapeutic target for BPA-induced neurodegenerative pathological changes.

Keywords: Bisphenol A; CDK5/GSK3β/PP2A/p-Tau axis; In vivo study; Perinatal exposure; Tauopathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzhydryl Compounds / toxicity*
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / enzymology
  • Cerebral Cortex / pathology
  • Cyclin-Dependent Kinase 5 / metabolism*
  • Dendritic Spines / drug effects
  • Dendritic Spines / enzymology
  • Dendritic Spines / pathology
  • Endocrine Disruptors / toxicity*
  • Female
  • Gestational Age
  • Glycogen Synthase Kinase 3 beta / metabolism*
  • Hippocampus / drug effects*
  • Hippocampus / enzymology
  • Hippocampus / pathology
  • Male
  • Maternal Exposure
  • Mice, Inbred C57BL
  • Neurotoxicity Syndromes / enzymology
  • Neurotoxicity Syndromes / etiology*
  • Neurotoxicity Syndromes / pathology
  • Phenols / toxicity*
  • Phosphorylation
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Protein Phosphatase 2 / metabolism*
  • tau Proteins / metabolism*

Substances

  • Benzhydryl Compounds
  • Endocrine Disruptors
  • Mapt protein, mouse
  • Phenols
  • tau Proteins
  • Cyclin-Dependent Kinase 5
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, mouse
  • Cdk5 protein, mouse
  • Protein Phosphatase 2
  • bisphenol A